Stueland Katherine

CHIEF EXECUTIVE OFFICER, DirectorGeneDx Holdings Corp. (WGS) · full profile →Form 4 · filed May 1, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$142K
Net Open-Market Flow
-$142K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 29, 2026Option exercise(M)4K$095K
Apr 29, 2026Sell(S)2K$65.20$140K93K
Apr 29, 2026Sell(S)18$64.12$1K93K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 29, 2026Option exercise(M)4K$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001689575-26-000024) within minutes of acceptance. Every field above traces to the original document. Verify it directly: